InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,921.15
(
0.21%
)
Post# of 251789
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119609
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: CT post# 221581

Tuesday, 10/23/2018 2:12:49 PM

Tuesday, October 23, 2018 2:12:49 PM

Post# of 251789
ENTA—This is the ct.g listing for the phase-2 RSV trial:

https://www.clinicaltrials.gov/ct2/show/NCT03691623

There is only one trial site listed so far (in the UK), so enrolling 114 subjects may take several months. Once fully enrolled, the trial should finish up pretty quickly.

Is it difficult to enroll for this type of trial?

I wouldn't expect it to be unusually difficult insofar as the trial is using healthy volunteers.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up